Waldemar Och

550 total citations
27 papers, 361 citations indexed

About

Waldemar Och is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Waldemar Och has authored 27 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Waldemar Och's work include Glioma Diagnosis and Treatment (10 papers), Brain Metastases and Treatment (8 papers) and Meningioma and schwannoma management (6 papers). Waldemar Och is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Brain Metastases and Treatment (8 papers) and Meningioma and schwannoma management (6 papers). Waldemar Och collaborates with scholars based in Poland, Germany and United States. Waldemar Och's co-authors include Renata Duchnowska, Anna Kowalczyk, Jacek Jassem, Wojciech Biernat, Wojciech Olszewski, Tomasz Mandat, Bożena Jarosz, Tomasz Trojanowski, Barbara Radecka and Bogumiła Czartoryska-Arłukowicz and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Waldemar Och

26 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Waldemar Och Poland 10 175 133 118 116 85 27 361
Prit Benny Malgulwar India 13 68 0.4× 132 1.0× 143 1.2× 227 2.0× 128 1.5× 27 422
Henning Leske Switzerland 10 85 0.5× 67 0.5× 160 1.4× 125 1.1× 79 0.9× 25 396
Camille Derderian United States 6 116 0.7× 145 1.1× 65 0.6× 218 1.9× 119 1.4× 8 408
Yangzhi Qi China 12 83 0.5× 125 0.9× 99 0.8× 162 1.4× 112 1.3× 26 408
Toshihide Tsuzuki Japan 7 97 0.6× 112 0.8× 179 1.5× 132 1.1× 68 0.8× 17 352
Erell Guillerm France 9 102 0.6× 68 0.5× 82 0.7× 114 1.0× 153 1.8× 21 351
K. Carson United States 5 71 0.4× 48 0.4× 118 1.0× 139 1.2× 67 0.8× 16 345
Alicia Lenzen United States 7 133 0.8× 75 0.6× 84 0.7× 183 1.6× 77 0.9× 25 437
Luyan Mu China 12 106 0.6× 63 0.5× 107 0.9× 188 1.6× 137 1.6× 20 383
Paulina Kober Poland 14 114 0.7× 64 0.5× 107 0.9× 274 2.4× 151 1.8× 36 566

Countries citing papers authored by Waldemar Och

Since Specialization
Citations

This map shows the geographic impact of Waldemar Och's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waldemar Och with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waldemar Och more than expected).

Fields of papers citing papers by Waldemar Och

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waldemar Och. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waldemar Och. The network helps show where Waldemar Och may publish in the future.

Co-authorship network of co-authors of Waldemar Och

This figure shows the co-authorship network connecting the top 25 collaborators of Waldemar Och. A scholar is included among the top collaborators of Waldemar Och based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Waldemar Och. Waldemar Och is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jesionek‐Kupnicka, Dorota, et al.. (2023). Immunohistochemical detection of EGFRvIII in glioblastoma – Anti-EGFRvIII antibody validation for diagnostic and CAR-T purposes. Biochemical and Biophysical Research Communications. 685. 149133–149133. 2 indexed citations
2.
Duchnowska, Renata, Anna Supernat, Rafał Pęksa, et al.. (2022). Pathway-level mutation analysis in primary high-grade serous ovarian cancer and matched brain metastases. Scientific Reports. 12(1). 20537–20537. 4 indexed citations
3.
4.
Stec, Wojciech J., Magdalena Książkiewicz, Marta Popęda, et al.. (2017). Low Incidence along with Low mRNA Levels of EGFRvIII in Prostate and Colorectal Cancers Compared to Glioblastoma. Journal of Cancer. 8(1). 146–151. 14 indexed citations
5.
Och, Waldemar, Tomasz Szmuda, Beata Sikorska, et al.. (2016). Recurrence-associated chromosomal anomalies in meningiomas: Single-institution study and a systematic review with meta-analysis. Neurologia i Neurochirurgia Polska. 50(6). 439–448. 6 indexed citations
6.
Och, Waldemar, et al.. (2016). The molecular pattern of histopathological progression to anaplastic meningioma – A case report. Neurologia i Neurochirurgia Polska. 50(4). 288–293.
7.
Duchnowska, Renata, Rafał Pęksa, Barbara Radecka, et al.. (2016). Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis. Breast Cancer Research. 18(1). 43–43. 83 indexed citations
8.
Rutkowski, Robert, et al.. (2016). Survivin, caspase-3 and MIB-1 expression in astrocytic tumors of various grades. Advances in Medical Sciences. 61(2). 237–243. 14 indexed citations
9.
Och, Waldemar, Tomasz Szmuda, Beata Sikorska, et al.. (2016). The correlation of clinical and chromosomal alterations of benign meningiomas and their recurrences. Neurologia i Neurochirurgia Polska. 50(6). 395–402. 1 indexed citations
10.
Jesionek‐Kupnicka, Dorota, Małgorzata Szybka, Beata Małachowska, et al.. (2014). TP53 Promoter Methylation in Primary Glioblastoma: Relationship with TP53 mRNA and Protein Expression and Mutation Status. DNA and Cell Biology. 33(4). 217–226. 22 indexed citations
11.
Stoczyńska-Fidelus, Ewelina, Sylwester Piaskowski, Michał Bieńkowski, et al.. (2014). The Failure in the Stabilization of Glioblastoma-Derived Cell Lines: Spontaneous In Vitro Senescence as the Main Culprit. PLoS ONE. 9(1). e87136–e87136. 23 indexed citations
12.
Stoczyńska-Fidelus, Ewelina, Waldemar Och, Piotr Rieske, et al.. (2014). Spontaneous in vitro senescence of glioma cells confirmed by an antibody against IDH1R132H.. PubMed. 34(6). 2859–67. 13 indexed citations
13.
Duchnowska, Renata, Rafał Dziadziuszko, Tomasz Trojanowski, et al.. (2012). Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain. Breast Cancer Research. 14(4). R119–R119. 77 indexed citations
14.
Stawski, Robert, Sylwester Piaskowski, Ewelina Stoczyńska-Fidelus, et al.. (2012). Reduced expression of ELAVL4 in male meningioma patients. Brain Tumor Pathology. 30(3). 160–166. 13 indexed citations
15.
Duchnowska, Renata, Jacek Jassem, Mangesh A. Thorat, et al.. (2009). Molecular characteristics of matched brain metastasis (BM) versus the primary breast cancer (PBC).. Cancer Research. 69(2_Supplement). 2028–2028. 1 indexed citations
16.
Woźniak, Kinga, Sylwester Piaskowski, Ewa Golańska, et al.. (2008). BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region. Cancer Genetics and Cytogenetics. 183(1). 14–20. 17 indexed citations
17.
Jesionek‐Kupnicka, Dorota, Izabela Zawlik, Małgorzata Szybka, et al.. (2008). High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations. Cancer Genetics and Cytogenetics. 188(2). 77–82. 28 indexed citations
18.
Słoniewski, Paweł, et al.. (2008). Aneurysm of the meningeal branch of the occipital artery connecting with the distal portion of the posteroinferior cerebellar artery by the dural fistula.. PubMed. 67(4). 292–5. 3 indexed citations
19.
Och, Waldemar, et al.. (2002). [Vascular endothelial growth factor expression in cerebral neoplasms].. PubMed. 35(6). 1071–9. 4 indexed citations
20.
Och, Waldemar, et al.. (2001). [Correlation of expression of progesterone receptors with histopathological type and grade of malignancy of cerebral neoplasms].. PubMed. 35 Suppl 5. 110–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prit Benny Malgulwar Breakdown of academic impact, for papers by Henning Leske Breakdown of academic impact, for papers by Camille Derderian Breakdown of academic impact, for papers by Yangzhi Qi Breakdown of academic impact, for papers by Toshihide Tsuzuki Breakdown of academic impact, for papers by Erell Guillerm Breakdown of academic impact, for papers by K. Carson Breakdown of academic impact, for papers by Alicia Lenzen Breakdown of academic impact, for papers by Luyan Mu Breakdown of academic impact, for papers by Paulina Kober
Rankless by CCL
2026